Industry News

CRISPR Lipid-Lowering Race Heats Up as Scribe Seeks $75 Million to Advance Epigenetic Silencing

📅 15 July.2026

Read More →

PCSK9 Gene Editing Advances: NEJM & Nature Medicine Clinical Insights and PCSK9 KO Cell Lines

📅 11 June.2026

Read More →

One Infusion, Permanent DNA Editing? CRISPR May Be Entering the Therapeutic Era

📅 28 May.2026

Read More →

Rewriting CRISPR Rules: DNA-Guided Cas12a Enables Precise RNA Cleavage

📅 26 May.2026

Read More →

Nobel Laureate Jennifer Doudna Launches Aurora Therapeutics to Scale Personalized CRISPR Therapies for Rare Diseases

📅 29 January.2026

Read More →

From Double Helix to Outpatient Cures: How Nobel Prizes Ignited the Gene Therapy Revolution

📅 19 January.2026

Read More →

At Just One Year Old, He Joins Nature's 10: The Story of a CRISPR Breakthrough

📅 22 December.2025

Read More →

[Weekly News]: High-Impact Nature Study—CRISPR Library Screening Unveils Synthetic Lethality Potential of PELO Gene in Two Cancer Subtypes

📅 17 February.2025

Read More →

New Insights into Type III CRISPR System: Cryo-EM Reveals Selective Synthesis of Cyclic Oligoadenylates (cOA) as a Second Messenger in the System

📅 10 February.2025

Read More →

[Weekly News] Breakthrough in Gene Editing: Overcoming Immunogenicity with Cas Enzyme Mutants

📅 9 January.2025

Read More →

[Weekly News] CRISPR Library Screening Uncovers ALCAM as a Novel Molecular Target for Human Adenovirus B

📅 6 January.2025

Read More →

[Weekly News] CRISPR-StAR: High-Resolution Genetic Screening Innovation

📅 27 December.2024

Read More →

[Weekly News]CRISPR screening reveals synthetic lethal interactions in cancer, providing new targets for therapy

📅 20 December.2024

Read More →

[Weekly News] Multiplexed CRISPR Arrayed Libraries: Advancing Whole-Genome Targeting for Knockout, Activation, and Silencing Research

📅 13 December.2024

Read More →

[Weekly News] CRISPR Library Screening: The Key Role of EV-DNA Structure in Kupffer Cell Mediated Antitumor Immunity

📅 9 December.2024

Read More →